About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT06375499

Performance and Safety of T2769 Versus Hylo-Forte® in the Treatment of Moderate to Severe Dry Eye Syndrome.

The objective is to demonstrate the non-inferiority of T2769 compared to Hylo-Forte® in terms of the change from baseline (D1) in total ocular surface staining score assessed on Oxford 0-15 scale, in ...

Lead sponsor: Laboratoires Thea•4 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Laboratoires Thea

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Informed consent signed and dated (obtained prior to initiating any procedures).
•Patient aged ≥18 years old.
•Persistence of dry eye syndrome, despite artificial tears use in the previous month prior to the screening visit

Exclusion Criteria

•Far Best-Corrected Visual Acuity (BCVA) ≥+0.7 LogMar (e.g., ≤0.2 in decimal value or ≤20/100 Snellen equivalent or ≤50 letters Early Treatment Diabetic Retinopathy Study (ETDRS)).
•Patient with previous or current ophthalmic condition

Related studies

Autologous Serum Eye Drops in Dry Eye Syndrome

NCT07295691 · Autologous Serum Eye Drops, Dry Eye Syndrome

Clinical Applications of Advanced Ophthalmic Imaging

NCT03135327 · Multiple Sclerosis, Dry Eye Syndromes, and more

Assessment of TFT by OCT in Healthy Subjects and Subjects With DES

NCT02585414 · Dry Eye Syndromes

Difference of Tear Ferning Between Women with and Without Menopausal.

NCT06848829 · Dry Eye Syndromes

Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome

NCT06771427 · Dry Eye Syndrome (DES), Sjogren's Syndrome, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 2, 2026Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment74

Start dateSep 2024

Last updatedJan 2, 2026

Condition

Dry Eye Syndrome

Locations shown

OFTEX, s.r.o.

Prague

Axon Clinical, s.r.o.

Prague

Ganglion Medical Center

Pécs, Baranya

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 2, 2026Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions